The natural history of Unverricht-Lundborg disease: A report of eight genetically proven cases

Movement Disorders

Volumn 23, Issue 1, 2008, Pages 107-113

  Chew, Nee K ^a   Mir, Pablo ^a,b   Edwards, Mark J ^a   Cordivari, Carla ^c   Martino, Davide ^a,d   Schneider, Susanne A ^a   Kim, Hee Tae ^a   Quinn, Niall P ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

Baltic myoclonus; Myoclonus; Natural history; Unverricht Lundborg

Indexed keywords

ACETAZOLAMIDE; ACETYLCYSTEINE; ALCOHOL; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; LISURIDE; NITRAZEPAM; ORAL CONTRACEPTIVE AGENT; PHENETURIDE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PRIMIDONE; TOPIRAMATE; TRYPTOPHAN; VALPROIC ACID;

ADOLESCENT; ADULT; APRAXIA; ARTICLE; CEREBELLAR ATAXIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONFUSION; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; DYSTONIA; ELECTROENCEPHALOGRAM; EVOKED VISUAL RESPONSE; EYE MOVEMENT DISORDER; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HORMONE SUBSTITUTION; HUMAN; MALE; MYOCLONUS; MYOCLONUS EPILEPSY; NAUSEA; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SOCIAL STATUS; SURVIVAL RATE; WALKING AID; WHEELCHAIR;

EID: 39549120695     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21812     Document Type: Article

References (31)

1. Marseille Consensus Group. Classification of progressive myoclonus epilepsies and related disorders. Ann Neurol 1990;28:113-116.
2. Unverricht H. Die myoclonie. Leipzig: Franz Deuticke; 1891. p 1-128.
3. Norio R, Koskiniemi M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet 1979;15:382-398.
4. Koskiniemi M, Donner M, Majuri H, Haltia M, Norio R. Progressive myoclonus epilepsy. A clinical and histopathological study. Acta Neurol Scand 1974;50:307-332.
5. Koskiniemi M, Toivakka EI, Donner M. Progressive myoclonus epilepsy: electroencephalographical findings. Acta Neurol Scand 1974;30:333-359.
6. Pennacchio LA, Lehejoski AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-1734.
7. Lalioti MD, Scott HS, Genton P, et al. A PCR amplification method reveals instability of the dodecamer repeat in Progressive Myoclonus Epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. Am J Hum Genet 1998;62:842-847.
8. Virtaneva K, D'Amato E, Miao J, et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 1997;15:393-396.
9. Lalioti MD, Scott HS, Buresi C, et al. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 1997;386:847-851.
10. Leino E, Partanen J, Helkala EL, Riekkinen PJ. Clinical stages of progressive myoclonus epilepsy in adult patients. Acta Neurol Scand 1982;65:19-29.
11. Harenko A, Toivakka EI. Myoclonus epilepsy (Unverricht-Lundborg) in Finland. Acta Neurol Scand 1961;37:282-296.
12. Koskiniemi M. Psychological findings in progressive myoclonus epilepsy without Lafora bodies. Epilepsia 1974;15:537-545.
13. Haltia M, Kristensson K, Sourander P. Neuropathological studies in three Scandinavian cases of progressive myoclonic epilepsy. Acta Neurol Scand 1969;45:63-77.
14. Valzania F, Strafella AP, Tropeani A, Rubboli G, Nassetti SA, Tassinari CA. Facilitation of rhythmic events in progressive myoclonus epilepsy: a transcranial magnetic stimulation study. Clin Neurophysiol 1999;110:152-157.
15. Manganotti P, Tamburin S, Zanette G, Fiaschi A. Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology 2001;57:1793-1799.
16. Silen T, Forss N, Jensen O, Hari R. Abnormal reactivity of the approximately 20-Hz motor cortex rhythm in Unverricht Lundborg type progressive myoclonus epilepsy. Neuroimage 2000;12:707-712.
17. 1H MRS study. Neurology 2002;58:1686-1689.
18. Bhatia KP, Brown P, Gregory R, et al. Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 1995;118 (Part 5):1087-1093.
19. Tijssen MA, Thom M, Ellison DW, et al. Cortical myoclonus and cerebellar pathology. Neurology 2000;54:1350-1356.
20. Brown P, Steiger MJ, Thompson PD, et al. Effectiveness of piracetam in cortical myoclonus. Mov Disord 1993;8:63-68.
21. Papacostas S, Kkolou E, Papathanasiou E. Levetiracetam in three cases of progressive myoclonus epilepsy. Pharm World Sci 2007; 29:164-166.
22. Edwards MJ, Hargreaves IP, Heales SJR, et al. N-acetylcysteine and Unverricht-Lundborg disease. Variable response and possible side effects. Neurology 2002;59:1447-1449.
23. Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res 2000;40:33-39.
24. Hurd RW, Wilder BJ, Helveston WR, Uthman BM. Treatment of progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Neurology 1996;47:1264-1268.
25. Genton P, Guerrini R. Antimyoclonic effects of alcohol in progressive myoclonic epilepsy. Neurology 1990;40:1412-1416.
26. Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ. "Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by Phenytoin. Lancet 1983;2:838-842.
27. Genton P, Gelisse P, Crespel A. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease. Epilepsia 2006;47:2083-2085.
28. Mervaala E, Keranen T, Paakkonen A, Partanen JV, Riekkinen P. Visual evoked potentials, brainstem auditory evoked potentials and quantitative EEG in Baltic progressive myoclonus epilepsy. Epilepsia 1986;27:542-547.
29. Ferlazzo E, Magaudda A, Striano P, Vi-Hong N, Serra S, Genton P. Long-term evolution of EEG in Unverricht-Lundborg disease. Epilepsy Res 2007;73:219-227.
30. Tassinari CA, Avanzini G, Michelucci R, et al. Clinical and neurophysiological findings of genetically proven Unverricht-Lundborg disease in Italy. Epilepsia 1998;39:214.
31. Lehesjoki AE, Koskiniemi M. Clinical features and genetics of progressive myoclonus epilepsy of the Unverricht-Lundborg type. Ann Med 1998;30:474-480.